duocarmycin sa has been researched along with Neoplasms, Bronchial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haunert, F; Herzig, T; Lieb, M; Schuberth, I; Tietze, LF | 1 |
1 other study(ies) available for duocarmycin sa and Neoplasms, Bronchial
| Article | Year |
|---|---|
A strategy for tumor-selective chemotherapy by enzymatic liberation of seco-duocarmycin SA-derivatives from nontoxic prodrugs.
Topics: Antibiotics, Antineoplastic; Antibodies; Bronchial Neoplasms; Duocarmycins; Humans; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Prodrugs; Pyrroles; Tumor Cells, Cultured | 2001 |